CD8A and neoplasm: More importantly, CD8+ TIL from B16F10E-KO was much more strongly enriched with granzyme B+ T cells than B16F10E untreated or treated with anti-PD-1, with no further enrichment after PD-1 blockade in the former tumours (Fig. 5f).